Feminization Assignment

This condition may cause clinically significant distress or impairment in social, occupational or other important areas of functioning.Gender reassignment surgery is performed to change primary and/or secondary sex characteristics.D.) whereas male to female (MTF) trans identified individuals hoped to begin feminizing hormone therapy as early as age 12.5 /- 4.0, before presenting secondary sex characters.

This condition may cause clinically significant distress or impairment in social, occupational or other important areas of functioning.Gender reassignment surgery is performed to change primary and/or secondary sex characteristics.D.) whereas male to female (MTF) trans identified individuals hoped to begin feminizing hormone therapy as early as age 12.5 /- 4.0, before presenting secondary sex characters.

Tags: Dissertation Binden Lassen WienExample Of Creative Writing Short StoryWriting Application EssaysWhen To Indent Paragraphs In An EssayAyn Rand Novels Org Essay SMba 2012 EssaysProblem Solving MeansProblem Solving Vs Decision MakingThe French Revolution Essay

Awareness of the condition appears to be increasing, probably because of greater societal acceptance and available hormonal treatment.

Therapeutic options include hormone and surgical treatments but may be limited by insurance coverage because costs are high.

For male to female gender reassignment, surgical procedures may include genital reconstruction (vaginoplasty, penectomy, orchidectomy, clitoroplasty) and cosmetic surgery (breast implants, facial reshaping, rhinoplasty, abdominoplasty, thyroid chondroplasty (laryngeal shaving), voice modification surgery (vocal cord shortening), hair transplants) (Day, 2002).

For female to male gender reassignment, surgical procedures may include mastectomy, genital reconstruction (phalloplasty, genitoplasty, hysterectomy, bilateral oophorectomy), mastectomy, and cosmetic procedures to enhance male features such as pectoral implants and chest wall recontouring (Day, 2002).

The authors concluded that transgender persons seeking hormonal therapy are being seen with increasing frequency.

The dysphoria present in many transgender persons is associated with significant mood disorders that interfere with successful careers.

On the other hand, the 6th (2001) and the 7th (2011) versions of the standards of care for the health of transsexual, transgender, and gender non-conforming people of World Professional Association for Transgender Health (WPATH) recommend that transgender adolescents (Tanner stage 2, [mainly 12 to 13 years of age]) are treated by the endocrinologists to suppress puberty with gonadotropin-releasing hormone (Gn RH) agonists until age 16 years old, after which cross-sex hormones may be given.

A questionnaire on 181 people with GID diagnosed in the Okayama University Hospital (Japan) showed that female to male (FTM) trans identified individuals hoped to begin masculinizing hormone therapy at age of 15.6 /- 4.0 (mean /- S.

For patients seeking MTF affirmation, hormone treatment includes estrogens, finasteride, spironolactone, and Gn RH analogs.

Surgical options include feminizing genital and facial surgery, breast augmentation, and various fat transplantations.